Bharat Rasayan is currently trading at Rs. 7143.50, up by 223.45 points or 3.23% from its previous closing of Rs. 6920.05 on the BSE.
The scrip opened at Rs. 6838.00 and has touched a high and low of Rs. 7195.00 and Rs. 6837.00 respectively. So far 608 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 7980.00 on 10-Feb-2020 and a 52 week low of Rs. 3352.10 on 18-Feb-2019.
Last one week high and low of the scrip stood at Rs. 7697.85 and Rs. 6700.05 respectively. The current market cap of the company is Rs. 3027.23 crore.
The promoters holding in the company stood at 74.83%, while Institutions and Non-Institutions held 0.53% and 24.64% respectively.
Bharat Rasayan has executed a Joint Venture (JV) Agreement on February 18, 2020, with Nissan Chemical Corporation (NCC), a company incorporated in Japan, and with Nissan Bharat Rasayan, a company incorporated in India (JV Company). The joint venture will operate through a company named Nissan Bharat Rasayan, a company incorporated in India.
This Joint Venture is expected to bring benefits to both the JV Partners i.e. Bharat Rasayan and Nissan Chemical Corporation. The Joint Venture Company i.e. Nissan Bharat Rasayan has decided to construct new manufacturing factory in India for various technical products.
Bharat Rasayan, part of the Bharat Group of companies, is engaged in manufacturing technical grade pesticides, pesticides formulations and intermediates.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: